Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Biopharma’s 5 Biggest M&A Deals of 2022
BioSpace
Wed, 12/14/22 - 10:50 am
M&A
Amgen
Horizon Therapeutics
Pfizer
Biohaven
Global Blood Therapeutics
Bristol Myers Squibb
Turning Point Therapeutics
ChemoCentryx
In struggling Vallon, NKT-focused GRI Bio spots opportunity to jump onto Nasdaq
Fierce Biotech
Wed, 12/14/22 - 10:47 am
Vallon Pharmaceuticals
GRI Bio
M&A
Tandem agrees to buy AMF, challenging Insulet for insulin pump patch market
Medtech Dive
Wed, 12/14/22 - 10:42 am
Tandem Diabetes Care
AMF Medical
M&A
Medtech
devices
insulin pump patch
Tandem Set for M&A in One of Diabetes Tech Most Eventful Years
Medical Devices and Diagnostics Industry
Tue, 12/13/22 - 11:49 pm
Tandem Diabetes Care
Medtech
M&A
diabetes
Merck initiates cash tender offer to buy Imago BioSciences
Pharmaceutical Business Review
Tue, 12/13/22 - 10:26 am
Merck
M&A
Imago BioSciences
Amgen to Buy Horizon in Biotech’s Biggest Deal of 2022
BioSpace
Mon, 12/12/22 - 10:34 am
Amgen
Horizon Therapeutics
M&A
Boston Scientific to Take Majority Stake in Chinese Medtech Company
Medical Devices and Diagnostics Industry
Mon, 12/12/22 - 10:18 am
Medtech
devices
Boston Scientific
China
Acotec
M&A
Life sciences M&A values halve, volumes plunge. Will we ever see deals pick up again?
Fierce Biotech
Thu, 12/8/22 - 10:41 am
M&A
life sciences
Illumina loses its grip: the sequencing giant’s acquisition of Grail is heading for the rocks
EP Vantage
Tue, 12/6/22 - 08:50 pm
Illumina
M&A
Grail
Janssen Bows Out as Contender for Horizon Therapeutics Buyout
BioSpace
Mon, 12/5/22 - 10:59 am
Horizon Therapeutics
M&A
Agmen
Sanofi
Janssen
JNJ
Boston Scientific's struggle with obesity
EP Vantage
Mon, 12/5/22 - 10:44 am
Medtech
devices
Boston Scientific
obesity
Apollo Endosurgery
M&A
Apollo ESG
Amid Buyout Buzz, Mirati Pushes Phase III NSCLC Study to Final Analysis
BioSpace
Sun, 12/4/22 - 01:17 pm
Mirati Therapeutics
clinical trials
M&A
non-small cell lung cancer
sitravantinib
With buyout on Horizon, Amgen and Sanofi eye cash plays for rare disease drug maker
Fierce Pharma
Fri, 12/2/22 - 11:13 am
Horizon Therapeutics
Sanofi
Amgen
M&A
Large pharmas probe takeover of Horizon Therapeutics
BioPharma Dive
Wed, 11/30/22 - 10:58 am
Horizon Pharma
M&A
JNJ
Sanofi
Amgen
Boston Scientific's $615M Apollo Bid Carries Weight with Analysts
Medical Devices and Diagnostics Industry
Tue, 11/29/22 - 10:50 pm
Medtech
M&A
Boston Scientific
Apollo Endosurgery
endoscopy
AstraZeneca Deepens Cancer Cell Therapy Portfolio with Neogene Buyout
BioSpace
Tue, 11/29/22 - 11:12 am
AstraZeneca
Neogene Therapeutics
M&A
cancer
cell therapy
Mirati is once again the subject of Big Pharma takeover talks: report
Fierce Biotech
Sun, 11/27/22 - 07:08 pm
Mirati Therapeutics
M&A
Amgen
Lumakras
CardieX Acquires Blumio, Incorporates Its Wearable Blood Pressure Sensor
MedCity News
Tue, 11/22/22 - 10:36 am
CardieX
M&A
Blumio
cardiovascular sensors
blood pressure sensors
Medtech
Merck & Co. inks $1.4B blood cancer biotech buyout to muscle in on Bristol Myers, Novartis
Fierce Biotech
Mon, 11/21/22 - 10:34 am
Merck
M&A
Imago BioSciences
blood cancer
Nordic Nanovector comment on Proposed Merger with APIM Therapeutics
BioSpace
Mon, 11/21/22 - 09:56 am
Nordic Nanovector
APIM Therapeutics
M&A
Pages
« first
‹ previous
…
22
23
24
25
26
27
28
29
30
…
next ›
last »